| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/19/2009 | WO2008116107A3 Piperazine derivatives as glucokinase activators |
| 03/19/2009 | WO2008110690A3 Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents |
| 03/19/2009 | WO2008104306A3 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
| 03/19/2009 | WO2008079404A3 Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| 03/19/2009 | WO2008078176A9 Methods, compounds, and compositions for treating metabolic disorders and diabetes |
| 03/19/2009 | WO2008070579A3 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 03/19/2009 | WO2008063933A3 Pak modulators |
| 03/19/2009 | WO2008063157A3 A nanoparticle-based anticoagulant |
| 03/19/2009 | WO2008039139A8 Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
| 03/19/2009 | WO2008039138A8 Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derivatives and their use in therapy |
| 03/19/2009 | WO2008037258A8 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 03/19/2009 | WO2008032099A3 Process for the preparation of montelukast, and intermediates therefor |
| 03/19/2009 | WO2008005511A8 Novel inhibitors of hepatitis c virus replication |
| 03/19/2009 | WO2007122580A3 Compositions of phenylephrine useful for treatment of respiratory illness |
| 03/19/2009 | WO2005086684A3 Method for modulating, regulating and/or stabilizing angiogenesis |
| 03/19/2009 | US20090077677 Mammalian grainyhead transcription factors |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076264 Deuterium-enriched rivaroxaban |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
| 03/19/2009 | US20090076171 Metallofullerols and their Applications for Preparation of Medicine for Inhibition of Tumor Growth |
| 03/19/2009 | US20090076170 Mixture of organic peroxide such as benzoyl peroxide and antioxidant such as butylated hydroxyltoluene; shelf life, storage stability; skin disorders, acne agents; cosmetics |
| 03/19/2009 | US20090076168 Amine-based and imine-based polymers, uses and preparation thereof |
| 03/19/2009 | US20090076167 Deuterium-enriched tramiprosate |
| 03/19/2009 | US20090076166 Enterically coated cystamine, cysteamine and derivatives thereof |
| 03/19/2009 | US20090076165 Deuterium-enriched memantine |
| 03/19/2009 | US20090076164 Treatment of pain |
| 03/19/2009 | US20090076163 Deuterium-enriched dapoxetine |
| 03/19/2009 | US20090076162 Deuterium-enriched desvenlafaxine |
| 03/19/2009 | US20090076161 Deuterium-enriched bupropion |
| 03/19/2009 | US20090076160 Use of R (+) -N-propargyl-1-aminoindan to treat or prevent hearing loss |
| 03/19/2009 | US20090076159 Deuterium-enriched eplivanserin |
| 03/19/2009 | US20090076158 Deuterium-enriched bicalutamide |
| 03/19/2009 | US20090076157 Deuterium-enriched senicapoc |
| 03/19/2009 | US20090076156 Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders |
| 03/19/2009 | US20090076155 benzoic acid derivatives, used as acetyltransferase enzyme inhibitors, used in the treatment of diseases due to defects in gene regulation predominantly cancer |
| 03/19/2009 | US20090076154 Deuterium-enriched vorinostat |
| 03/19/2009 | US20090076153 Deuterium-enriched tigecycline |
| 03/19/2009 | US20090076152 Novel Compounds Active as Muscarinic Receptor Antagonists |
| 03/19/2009 | US20090076151 Method for stimulating weight loss and/or for lowering triglycerides in patients |
| 03/19/2009 | US20090076150 Deuterium-enriched bromfenac |
| 03/19/2009 | US20090076149 Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride |
| 03/19/2009 | US20090076148 Deuterium-enriched pravastatin |
| 03/19/2009 | US20090076147 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/19/2009 | US20090076146 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 03/19/2009 | US20090076145 Deuterium-enriched amibegron |
| 03/19/2009 | US20090076144 Deuterium-enriched bazedoxifene |
| 03/19/2009 | US20090076143 Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts |
| 03/19/2009 | US20090076142 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 03/19/2009 | US20090076141 Use of Propofol Prodrugs for Treating Neuropathic Pain |
| 03/19/2009 | US20090076140 Pharmaceutical compositions containing sulphonic acid derivatives |
| 03/19/2009 | US20090076139 Deuterium-enriched oxalplatin |
| 03/19/2009 | US20090076138 Deuterium-enriched darunavir |
| 03/19/2009 | US20090076137 Deuterium-enriched dronedarone |
| 03/19/2009 | US20090076136 Therapeutic agent |
| 03/19/2009 | US20090076135 Deuterium-enriched hydromorphone |
| 03/19/2009 | US20090076134 Deuterium-enriched simvastatin |
| 03/19/2009 | US20090076133 Deuterium-enriched zanamivir |
| 03/19/2009 | US20090076132 Antiviral compositions and methods of treatment |
| 03/19/2009 | US20090076131 Anti-Cancer and Anti-Inflammatory Effects of Annurca Apple Extracts and Compositions Purified Therefrom |
| 03/19/2009 | US20090076130 Compounds for the inhibition of histone deacetylase |
| 03/19/2009 | US20090076129 Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, alpha-amylase and alpha-glucosidase activity in mammals |
| 03/19/2009 | US20090076128 Deuterium-enriched topiramate |
| 03/19/2009 | US20090076127 Deuterium-enriched larotaxel |
| 03/19/2009 | US20090076126 Deuterium-enriched enalapril |
| 03/19/2009 | US20090076125 Deuterium-enriched glimepiride |
| 03/19/2009 | US20090076124 Deuterium-enriched ropinirole |
| 03/19/2009 | US20090076123 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 03/19/2009 | US20090076122 PARP Modulators and Treatment of Cancer |
| 03/19/2009 | US20090076121 Deuterium-enriched sumatriptan |
| 03/19/2009 | US20090076120 Crystal of Aminopyrrolidine Derivative and Production Method Thereof |
| 03/19/2009 | US20090076119 Deuterium-enriched ramipril |
| 03/19/2009 | US20090076118 Deuterium-enriched saxagliptin |
| 03/19/2009 | US20090076117 Deuterium-enriched laropiprant |
| 03/19/2009 | US20090076116 Deuterium-enriched carvediolo |
| 03/19/2009 | US20090076115 Photosensitizers for Targeted Photodynamic Therapy |
| 03/19/2009 | US20090076114 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes |
| 03/19/2009 | US20090076112 Deuterium-enriched eltrombopag |
| 03/19/2009 | US20090076111 Methods for improving glycemic control in humans |
| 03/19/2009 | US20090076110 An amine salt of nitric acid and aginine, beta alanine, agmatine, citrulline, creatine, glutamine, L-histidine, isoleucine, leucine,norvaline, or ornithine; vasodilation; metabolism of mucle protein;exercise |
| 03/19/2009 | US20090076109 Pharmaceutical Composition for External Use |
| 03/19/2009 | US20090076108 Method for treating obesity |
| 03/19/2009 | US20090076107 Deuterium-enriched odansetron |
| 03/19/2009 | US20090076106 2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels |
| 03/19/2009 | US20090076105 Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke |
| 03/19/2009 | US20090076104 Deuterium-enriched losartan |
| 03/19/2009 | US20090076103 Stem cell differentiating agents and uses therefor |
| 03/19/2009 | US20090076102 Deuterium-enriched muraglitazar |
| 03/19/2009 | US20090076101 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 03/19/2009 | US20090076100 Deuterium-enriched gsk625433 |
| 03/19/2009 | US20090076099 Deuterium-enriched ixabepilone |
| 03/19/2009 | US20090076098 Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones |
| 03/19/2009 | US20090076097 Deuterium-enriched atazanavir |
| 03/19/2009 | US20090076095 Deuterium-enriched nicorandil |
| 03/19/2009 | US20090076094 Novel antibacterial compounds |
| 03/19/2009 | US20090076093 Deuterium-enriched rosiglitazone |
| 03/19/2009 | US20090076091 Indazole-heteroaryl derivatives |
| 03/19/2009 | US20090076089 Deuterium-enriched pantoprazole |
| 03/19/2009 | US20090076088 Thrombin Receptor Antagonists |
| 03/19/2009 | US20090076087 Deuterium-enriched etoricoxib |